Correlation Between Iteos Therapeutics and Arrowhead Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Iteos Therapeutics and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iteos Therapeutics and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iteos Therapeutics and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Iteos Therapeutics and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iteos Therapeutics with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iteos Therapeutics and Arrowhead Pharmaceuticals.
Diversification Opportunities for Iteos Therapeutics and Arrowhead Pharmaceuticals
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Iteos and Arrowhead is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Iteos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iteos Therapeutics are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Iteos Therapeutics i.e., Iteos Therapeutics and Arrowhead Pharmaceuticals go up and down completely randomly.
Pair Corralation between Iteos Therapeutics and Arrowhead Pharmaceuticals
Given the investment horizon of 90 days Iteos Therapeutics is expected to generate 0.77 times more return on investment than Arrowhead Pharmaceuticals. However, Iteos Therapeutics is 1.3 times less risky than Arrowhead Pharmaceuticals. It trades about 0.26 of its potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest 722.00 in Iteos Therapeutics on October 20, 2024 and sell it today you would earn a total of 78.00 from holding Iteos Therapeutics or generate 10.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iteos Therapeutics vs. Arrowhead Pharmaceuticals
Performance |
| Timeline |
| Iteos Therapeutics |
| Arrowhead Pharmaceuticals |
Iteos Therapeutics and Arrowhead Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iteos Therapeutics and Arrowhead Pharmaceuticals
The main advantage of trading using opposite Iteos Therapeutics and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iteos Therapeutics position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.| Iteos Therapeutics vs. Annexon | Iteos Therapeutics vs. Monte Rosa Therapeutics | Iteos Therapeutics vs. Design Therapeutics | Iteos Therapeutics vs. Erasca Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Correlations Find global opportunities by holding instruments from different markets |